Prot #XTMAB-16-202: A Long-Term Multicenter Open-Label Study to Evaluate the Long-Term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-Pulmonary Involvement

Project: Research project

Project Details

StatusActive
Effective start/end date2/7/24 → 2/7/27

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #XTMAB-16-202 // Prot #XTMAB-16-202)
  • Xentria, Inc. (Prot #XTMAB-16-202 // Prot #XTMAB-16-202)